Zimmer Biomet › Financials
Ten years from Zimmer Biomet’s own SEC filings. Fiscal years end in December.
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.67B | $7.80B | $7.93B | $7.98B | $6.13B | $6.83B | $6.94B | $7.39B | $7.68B | $8.23B | $8.51B | — |
| Operating income | $821.1M | $799.3M | $33.8M | $1.14B | $83.1M | $860.3M | $696.3M | $1.28B | $1.29B | $1.10B | $1.21B | — |
| Net income | $305.9M | $1.81B | −$379.2M | $1.13B | −$138.9M | $401.6M | $231.4M | $1.02B | $903.8M | $705.1M | $806.7M | — |
| Earnings per share, diluted | $1.51 | $8.90 | −$1.86 | $5.47 | −$0.67 | $1.91 | $1.10 | $4.88 | $4.43 | $3.55 | — | — |
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $634.1M | $524.4M | $542.8M | $617.9M | $802.1M | $478.5M | $375.7M | $415.8M | $525.5M | $591.9M | — | $410.0M |
| Total assets | $26.68B | $25.96B | $24.13B | $24.64B | $24.42B | $23.46B | $21.07B | $21.50B | $21.37B | $23.09B | — | $22.80B |
| Debt | $11.24B | $10.14B | $8.94B | $8.20B | $8.10B | $1.00B | $5.70B | $5.80B | $6.20B | $7.52B | — | $7.48B |
| Total liabilities | $17.01B | $14.23B | $12.85B | $12.25B | $12.22B | $10.79B | $9.04B | $9.01B | $8.89B | $10.39B | — | $10.17B |
| Shareholders' equity | $9.67B | $11.74B | $11.27B | $12.39B | $12.19B | $12.66B | $12.02B | $12.48B | $12.47B | $12.70B | — | $12.62B |
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.63B | $1.58B | $1.75B | $1.59B | $1.20B | $1.50B | $1.36B | $1.58B | $1.50B | $1.70B | $1.74B | — |
| Capital spending | $184.7M | $156.0M | $162.7M | $207.1M | $111.9M | $143.6M | $187.9M | $291.1M | $203.8M | $224.5M | $220.3M | — |
| Free cash flow | $1.45B | $1.43B | $1.58B | $1.38B | $1.09B | $1.36B | $1.17B | $1.29B | $1.30B | $1.47B | $1.52B | — |
| Buybacks | $415.5M | — | — | — | — | — | $126.4M | $692.2M | $868.0M | $487.0M | $750.8M | — |
| Dividends | $188.4M | $193.6M | $195.2M | $196.7M | $198.5M | $200.1M | $201.2M | $200.9M | $196.0M | $190.3M | $188.4M | — |
| Returned to shareholders | $603.9M | $193.6M | $195.2M | $196.7M | $198.5M | $200.1M | $327.6M | $893.1M | $1.06B | $677.3M | $939.2M | — |
| Stock-based pay | $57.3M | $53.7M | $65.5M | $84.3M | $73.8M | $76.0M | $105.0M | $99.8M | $101.0M | $90.2M | $98.2M | — |
Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count
$18.12B at $94.98 a share, with 190,737,689 shares outstanding as of Jul 30, 2026, from the cover of its latest SEC filing.
Revenue of $8.51B and net income of $806.7M in the last 12 months to Jun 2026.
Zimmer Biomet reported $7.48B of debt and $410.0M of cash and equivalents on its balance sheet in Jun 2026.
Yes. Operating cash flow minus capital spending was $1.52B in the last 12 months to Jun 2026.
$677.3M in buybacks and dividends in fiscal 2025, from the cash flow statement.
Free. Your email goes to Substack, which runs the newsletter. Privacy